Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine

Figures & data

Table 1 Blood Work Results During Hospitalization

	Blood Work on the Day of Admission	Blood Work on the Last Day of Hospitalization	Normal Range
WBC	7.6	19.7	4.0–11.0 UNIT- 10×3 uL
RBC	4.17	1.45	4.0–5.50. 10x6/uL
Hemoglobin	12.4	4.4	11.0–16.0 g/dL
Platelet	203	134	150–450. 10x3/uL
Sodium	134	153	136–145 mmol/L
Potassium	4.6	6	3.5–5.1 mmol/L
CO2	13	39	21–32 mmol/L
Anion gap	19	20	8–16 mEQ/L
BUN	21	61	7–18 mg/dL
S. Creatinine	6	2.7	0.6–1.3 mg/dL
GFR	6	16	>60 mL/min
Lactic acid	1.3	19.3	0.4–2.0 mmol/L
Calcium	8.4	5.3	8.5–10.1 mg/dL
Phosphorus	7.2	10.3	2.5–4.9 mg/dL
T. Bilirubin	0.3	0.6	0.2–1.0 mg/dL
AST	1422	2066	15–37 U/L
ALT	600	1746	12–78 U/L
CPK	>14,000	>14,000	26–192 U/L
CRP	74.0	17.8	<3.0 mg/L
Troponin	0.18	0.88	0.0–0.04 ng/mL
proBNP	1388	5391	5–450 pg/mL
ESR	28		0–30 mm/Hr
Carnitine level (Total and free)	Wnl

Abbreviations: WBC, White blood cell; RBC, Red blood cell; CO2, Bicarbonate; BUN, Blood Urea Nitrogen; GFR, Glomerular Filtration Rate; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; CPK, Creatine kinase; CRP, C-reactive protein; proBNP, NT-Pro-B-Natriuretic Peptide; ESR, Erythrocyte sedimentation rate.

Figure 1 Blood work on the day of admission and blood work on the last day of hospitalization.

Figure 2 Blood work on the day of admission and blood work on the last day of hospitalization.

Table 2 CSF Results

CSF Analysis		Reference Range
WBC	2	(0–5/cu mm)
RBC	2	(0.cu mm)
Glucose	73	(40–70 mg/dL)
Total protein	31.6	(15–60 mg/dL)
Myelin Basic Protein	8.7	(0.0–5.6 ng/mL)
VDRL	Negative
Herpes I/II	Negative
West Nile	Negative

Abbreviations: CSF, cerebrospinal fluid; WBC, white blood cell; RBC, red blood cell; VDRL, venereal disease research laboratory test.